Enanta Pharmaceuticals (ENTA) EBT Margin Growth (3y) (2015 - 2026)
Enanta Pharmaceuticals (ENTA) EBT Margin Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 9,237.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -120.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Enanta Pharmaceuticals | 369.97 Mn | 206.20 Mn | - | 13,512.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,512.00 |
| Dec 31, 2025 | 5,904.00 |
| Sep 30, 2025 | 619.00 |
| Jun 30, 2025 | 6,551.00 |
| Mar 31, 2025 | 1,903.00 |
| Dec 31, 2024 | -2,483.00 |
| Sep 30, 2024 | -5,816.00 |
| Jun 30, 2024 | 2,622.00 |
| Mar 31, 2024 | -4,001.00 |
| Dec 31, 2023 | -15,241.00 |
| Sep 30, 2023 | -7,706.00 |
| Jun 30, 2023 | -6,967.00 |
| Mar 31, 2023 | -17,544.00 |
| Dec 31, 2022 | -15,148.00 |
| Sep 30, 2022 | -14,658.00 |
| Jun 30, 2022 | -17,894.00 |
| Mar 31, 2022 | -18,186.00 |
| Dec 31, 2021 | -15,161.00 |
| Sep 30, 2021 | -19,504.00 |
| Jun 30, 2021 | -19,637.00 |